Page last updated: 2024-11-02

pemoline and Dyskinesia Syndromes

pemoline has been researched along with Dyskinesia Syndromes in 5 studies

Pemoline: A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children.
pemoline : A member of the class of 1,3-oxazoles that is 1,3-oxazol-4(5H)-one which is substituted by an amino group at position 2 and by a phenyl group at position 5. A central nervous system stimulant, it was used to treat hyperactivity disorders in children, but withdrawn from use following reports of serious hepatotoxicity.

Research Excerpts

ExcerptRelevanceReference
"We report two case histories of previously healthy patients who both developed persistent dyskinetic syndromes (spasmodic torticollis and cranial dystonia, respectively) following the intake of norpseudoephedrine (NPE) as an appetite suppressant."3.69Dyskinesias possibly induced by norpseudoephedrine. ( Dressler, D; Thiel, A, 1994)
" While there have been a few reports of tolerance, it is possible that these were a reflection of inadequate dosing rather than actual tolerance to the drug's therapeutic effects."1.27Evidence of lack of abuse or dependence following pemoline treatment: results of a retrospective survey. ( Bartenbach, DE; Davis, PM; Langer, DH; Menander, KB; Sweeney, KP, 1986)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kasim, S1
Jinnah, HA1
Thiel, A1
Dressler, D1
Shuster, J1
Sallee, FR1
Stiller, RL1
Perel, JM1
Everett, G1
Langer, DH1
Sweeney, KP1
Bartenbach, DE1
Davis, PM1
Menander, KB1

Other Studies

5 other studies available for pemoline and Dyskinesia Syndromes

ArticleYear
Pharmacologic thresholds for self-injurious behavior in a genetic mouse model of Lesch-Nyhan disease.
    Pharmacology, biochemistry, and behavior, 2002, Volume: 73, Issue:3

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e

2002
Dyskinesias possibly induced by norpseudoephedrine.
    Journal of neurology, 1994, Volume: 241, Issue:3

    Topics: Adult; Amphetamine; Appetite Depressants; Brain; Female; Humans; Magnetic Resonance Imaging; Methylp

1994
Adverse drug reaction. Pemoline and dyskinesia.
    Nursing, 1999, Volume: 29, Issue:2

    Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Humans; Mal

1999
Pemoline-induced abnormal involuntary movements.
    Journal of clinical psychopharmacology, 1989, Volume: 9, Issue:2

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Humans; Male; Movement Disorders; Pemoline

1989
Evidence of lack of abuse or dependence following pemoline treatment: results of a retrospective survey.
    Drug and alcohol dependence, 1986, Volume: 17, Issue:2-3

    Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; C

1986